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Abstract  
Obesity is associated with a number of complications that may increase the risk for chronic 
disease, including inflammation and dysfunctional high-density lipoprotein (HDL) particles. 
Scavenger receptor class B member 1 (SR-B1) is an HDL receptor found in the cell plasma 
membrane involved in cholesterol exchange and the initiation of intracellular signaling cascades. 
During the process of adipocyte (fat cell) formation (adipogenesis), there is a delicate balance of 
transcriptional programs that affect cholesterol transport and facilitate lipid accumulation. Mice 
fed a high fat diet have increased SR-B1 mRNA expression in adipose tissue depots. Furthermore, 
SR-B1 mRNA expression was significantly increased in mature adipocytes. In this study, 3T3-L1 
pre-adipocytes were differentiated into mature adipocytes and transfected with SR-B1 siRNA. 
There was a 70% suppression of SR-B1, indicating a successful knockdown. Mature adipocytes 
were stimulated through lipopolysaccharides (LPS) and macrophage-conditioned media (MCM) 
to determine SR-B1 function in inflammatory conditions. Inflammatory stimulations demonstrated 
that there is increased mRNA expression of the inflammatory marker monocyte chemoattractant 
protein 1 (MCP-1) when cells are treated with MCM or LPS, however no significant effects of 
SR-B1 silencing were observed. Future experiments will include performing additional trials for 
inflammatory experiments, conducting Western blot analysis to determine protein suppression, 
and using small molecules to inhibit SR-B1 lipid transfer activity, such as block-lipid transport 1.  
 
 
 
 
 
Literature Review  
Introduction 
Adipose tissue has the capacity to store large amounts of energy in the form of triglycerides. 
Adipose tissue is also the largest reservoir for cholesterol in the body (~25% of whole-body 
cholesterol in humans), and adipocytes depend upon pre-formed sterol uptake due to their limited 
cholesterol biosynthetic capacity.1 The majority of cholesterol in adipocytes comes from 
circulating lipoproteins, such as high-density lipoproteins (HDL), and adipocytes maintain 
cholesterol homeostasis primarily through regulating efflux.2 Cholesterol accumulates in 
proportion to triglycerides in adipose tissue,3 and cholesterol-loading enhances fatty acid uptake 
in adipocytes.4 Evidence suggests that cholesterol imbalance in adipocytes may contribute to 
adipocyte dysfunction.2,5 Cholesterol overload is an indicator of enlarged adipocytes. Cholesterol 
uptake from HDL by adipocytes is directed towards lipid droplets and insulin stimulates this 
process.6,7 
Obesity is characterized by excess adipose tissue, which may lead to chronic diseases such 
as type 2 diabetes and cardiovascular disease. Dysmetabolic conditions are attributed to the low-
grade systemic inflammation that occurs with obesity,8 which involves macrophage infiltration of 
adipose tissue. When adipocytes grow to the point where they can no longer accommodate any 
more triglycerides, they acquire a dysfunctional metabolic profile, leading to the secretion of 
inflammatory cytokines that will attract macrophages to the tissue. Adipocytes will become 
resistant to insulin, leading to ectopic lipid deposition and systemic inflammation.8 Altered 
cholesterol homeostasis is a characteristic of hypertrophied adipocytes in the obese state.2 Enlarged 
adipocytes from obese animals do not respond to hormones like adipocytes from lean controls and 
exhibit an altered metabolic state. The adipocytes in obese individuals contain more cholesterol 
than lean individuals because excess cholesterol is detrimental in the circulation and thus, needs 
to be taken up by adipocytes. Therefore, recognizing how cholesterol homeostasis and 
inflammatory pathways impact adipocytes is key to understanding many metabolic disorders.  
 
Scavenger Receptor Class B, Type 1 as an HDL Receptor and Cholesterol Sensor 
Scavenger Receptor Class B, Type 1 (SR-B1) plays an important role as a cholesterol 
sensor and in facilitating cellular cholesterol bidirectional flux.9 It has high affinity for 
apolipoprotein A-I (apoA-I) residing on high-density lipoprotein (HDL) particles, and is 
responsible for the uptake of cholesteryl esters from HDL by steroidogenic tissues and the liver,7 
where it is highly expressed. Furthermore, SR-B1 facilitates the bidirectional flux of free 
cholesterol and phospholipids between lipoproteins and the cell plasma membrane.9 SR-B1 was 
shown to be a plasma membrane cholesterol sensor through its C-terminal transmembrane 
domain.9 Because of its role in the efflux of cholesterol from cells to lipoproteins, SR-B1 plays a 
role in reverse cholesterol transport (RCT)9 and thus, eliminates excess cholesterol from the body.  
The function of SR-B1 as an HDL receptor in atherosclerosis and reverse cholesterol 
transport (RCT) has been extensively studied.10 Mice deficient in SR-B1 (SR-B1 knockout) 
display reduced RCT11 and increased atherosclerosis.12 On the contrary, hepatic overexpression of 
SR-B1 in mice reduced plasma HDL-C levels and lowered atherosclerosis,13 suggesting that SR-
B1 overexpression may promote cholesterol flux through RCT pathways.  
 
Role of Adipose SR-B1 in Lipid Homeostasis and Regulation by Metabolic Signals 
Adipose SR-B1 expression and intracellular location are regulated by insulin and refeeding 
in mice.7 There is in vivo evidence that insulin and angiotensin II can mediate HDL homeostasis 
through their regulation of SR-B1 translocation in adipose tissue.7 Insulin also induces the 
transcription of several genes involved in lipogenesis by activating the lipogenic transcription 
factors, sterol regulatory element binding-protein-1c (SREBP1c) and liver X receptor (LXR).14 
Intracellular sterol levels regulate SR-B1 gene expression via SREBP-1a, a transcription factor 
that binds to two sterol-responsive elements (SREs) on the SR-B1 promoter in rats.15 LXRα and β 
and peroxisome proliferator-activated receptors (PPAR)α and γ bind to distal LXRE and PPARE, 
respectively, on the human and rat SR-BI promoters.15 The nuclear receptor LXR is activated by 
oxidized cholesterol and induces the expression of target genes to help maintain cellular 
homeostasis in response to increased cellular cholesterol.16 LXR activation, via oxysterol-loading, 
increased lipid accumulation in adipocytes.17 In vitro studies using 3T3-L1 adipocytes showed that 
HDL induced lipogenesis by increasing LXR binding activity in a process independent of insulin,7 
demonstrating a link between adipose lipid storage and SR-B1-HDL interactions. Potentially, as 
adipocytes increase in size to store more triglycerides, more adipocyte SR-B1 is needed to provide 
cholesterol to the cells beyond their biosynthetic capabilities.  
In addition to LXR, PPARs are important ligand-activated nuclear receptors regulating 
lipid metabolism in cells. PPARγ, a PPAR subtype highly expressed in mature adipocytes, has 
anti-inflammatory properties and is critical for adipogenesis.18 PPARγ ligands, including fatty acid 
derivatives such as 15-deoxy-Δ12–14 prostaglandin J2, increased SR-B1 expression in human and 
mouse monocytes and macrophages.13 Furthermore, PPARγ activation using a PPARγ agonist 
drug increased SR-B1 mRNA and protein expression in mouse adipose tissue, which in turn 
increased cholesterol uptake from circulating HDL particles.19  In contrast to PPARγ, Pref-1, a 
growth factor highly expressed in 3T3-L1 pre-adipocytes, inhibits adipogenesis and its expression 
is suppressed during adipocyte maturation.20 Adiponectin (adipoQ) is an adipose-derived hormone 
down-regulated in obesity and regulated by PPAR.21 Low plasma adiponectin concentrations are 
associated with co-morbidities of obesity, such as type 2 diabetes, coronary heart disease, and 
hypertension.21 Furthermore, adiponectin decreased mRNA levels of inflammatory markers such 
as TNF- and NF-, and reduced anti-inflammatory marker IL-10 in mouse macrophages.8,21  
When adipocytes are under metabolic stress, such as under excess cholesterol 
accumulation, they become dysfunctional and increase the production of cytokines. Macrophage 
accumulation initiates metabolic dysfunction of adipose tissue through pro-inflammatory 
pathways.22 Macrophage-conditioned media (MCM) can stimulate a pro- inflammatory response 
in mature adipocytes.22 Lipopolysaccharide (LPS) is a pro-inflammatory molecule derived from 
the cell wall of gram-negative bacteria. Circulating LPS has been shown to be increased with 
obesity and is associated with adipose tissue inflammation and insulin resistance, and will inhibit 
adipocyte differentiation.23 In macrophages, SR-B1 can bind and internalize LPS,24 which can 
reduce their inflammatory response to LPS.25 A co-culture of adipocytes and macrophages in the 
presence of LPS enhanced the secretion of interleukin-6 and monocyte chemoattractant protein-1 
(MCP-1).22 In mice, hepatic SR-B1 was shown to be promote LPS clearance,25 furthering the 
evidence that SR-B1 has anti-inflammatory properties.  
SR-B1 helps regulate cholesterol transport across the plasma membrane, which can help 
traffic cholesterol away from extrahepatic tissues to prevent atherosclerosis.  The role of SR-B1 in 
RCT has been heavily studied in hepatocytes and macrophages, but its function in adipocytes has 
yet to be fully understood. Adipocyte SR-B1 expression and intracellular location are responsive 
to metabolic status. Evidence suggests that cholesterol imbalance in adipocytes may contribute to 
adipocyte dysfunction. However, information regarding SR-B1 function in adipocytes and role in 
obesity development is lacking. Experiments in mice have demonstrated that overall SR-B1 
suppression results in obesity, but tissue-specific SR-B1 expression, specifically in the adipocytes 
has not been determined. In addition, the role of SR-B1 during inflammatory states has not been 
investigated either.  
Methods 
Differentiation of 3T3-L1 pre-adipocytes  
3T3-L1 pre-adipocytes were thawed, seeded into T-75 flasks and incubated at 37C and 
5% CO2. The cells were maintained in 10% calf serum/Dulbecco’s Modified Eagle’s medium 
(DMEM) containing penicillin-streptomycin antibiotic until they reached 100% confluency. After 
2 days at 100% confluency, the cells were differentiated using an induction media containing 10% 
fetal bovine serum (FBS)/DMEM media, 500 mM 3-isobutyl-1-methylxantine (IBMX), 167 nM 
insulin (in 100 M HCl), and 1M dexamethasone. After 2 days in the induction media, the media 
was changed to 10% FBS + insulin 167 nM insulin (in 100 M HCl) and maintained in this media 
for 12 days until adipocytes became mature.   
 
Animals and Diets   
C57BL/6J mice (8 weeks of age, n = 56) were obtained from The Jackson Laboratory and allowed 
to acclimate for 2 weeks on chow diet. Mice were then fed 
either a purified high fat lard-based diet comprised of 60% 
energy from fat (HFD, n = 16) or a purified low fat diet 
containing 10% of energy from fat (LFD, n = 8).26 After 16 
weeks on this diet, mice were fasted for 6-8 hours before 
being euthanized. Adipose tissues were perfused with saline 
Figure 1 
before being harvested, snap-frozen in liquid N2 and stored at -80C. 
In a separate animal study26, C57BL/6J mice (6 weeks of age, n = 52) were fed a diet 
comprised of 60% kcal from fat for 10 weeks (HFD, n=14). Adipose tissue was obtained from the 
epididymal, mesenteric, inguinal, and retroperitoneal regions of the mice (Figure 1)25 for gene 
expression.  
 
RAW 264.7 Macrophage Culture  
RAW 264.7 murine macrophages were obtained from ATCC. The cells were seeded into T-75 
flasks and maintained in complete media containing 10% FBS/DMEM and penicillin-streptomycin 
antibiotic and incubated at 37C and 5% CO2. After 3 days, the macrophage-conditioned media 
was aspirated and frozen at -20C for future experiments. 
 
siRNA Knockdown  
When the adipocytes were fully mature (12 days post-differentiation), the cells were 
prepared for transfection by transferring them into 24-well plates. The adipocytes were dislodged 
from the flasks using 0.5 mg/mL collagenase and pelleted by centrifugation at 400 x g for 5 
Figure 2 
minutes. The collagenase solution was aspirated and complete culture media (10% FBS/DMEM) 
was added to the tubes. The cells were counted and plated at a concentration of 2.0 x 105 cells/well 
on a 12-well plate and allowed to incubate overnight at 37C and 5% CO2.  
Pooled siRNAs were obtained from Dharmacon (siGENOME SMARTpool) and used for 
knockdown of selective gene expression. Transfection was conducted using a complex containing 
siRNA and DeliverX Plus Reagent (Affymetrix) following a validated transfection protocol for 
3T3-L1 adipocytes (Panomics).27 The three siRNA (5 M each) used were scramble (negative 
control), cyclophilin (positive control), and SR-B1 (target gene) (Figure 2). To confirm 
knockdown of SR-B1, the cells were treated under 5 conditions 1) cells only 2) cells + transfection 
reagent 3) scramble 4) cyclophilin and 5) SR-B1. After transfection with siRNA + DeliverX, the 
cells were incubated for 4 hours at 37 C and 5% CO2 before 10% FBS/DMEM media was added. 
The cells were incubated for an additional 48 hours and were removed in TRIzol reagent for 
mRNA analysis. siRNA and transfection reagent were confirmed to work based on gene 
expression levels after treatment using real-time qRT-PCR. The SR-B1 expression was measured 
for the scramble siRNA and SR-B1 siRNA.  
Inflammation was simulated through either 10 ng/mL LPS or macrophage-conditioned 
media (MCM). After a 48-hour incubation in siRNA and transfection media, cells in each siRNA 
knockdown condition (scramble, cyclophilin, SR-B1) were treated with 10 ng/mL LPS for 4 hours 
before being removed in TRIzol reagent for mRNA analysis. For macrophage experiments, 1 mL 
of MCM was added to each experimental well and incubated for 4 hours before being collected in 
TRIzol reagent.  
 
 
RNA Isolation, cDNA synthesis, and real-time qPCR  
Total RNA was isolated using TRIzol reagent. Total RNA was treated with DNase I and 
reverse transcribed using iScript cDNA synthesis kit (BioRad). Gene expression was assessed by 
real-time quantitative polymerase chain reaction (qPCR) using iTaq Universal SYBR Green 
Supermix (BioRad). Gene expression was normalized to the expression of the reference gene, 36-
B4, using the 2-Ct method. Genes primers used are listed in Table 1.    
 
Statistical Analysis 
Data was analyzed using Graph Pad Prism 6. Means were compared using a one-way ANOVA 
test with Tukey’s post hoc comparisons, when appropriate, or Student’s t-test. Data are reported 
as mean ± SEM. Significance is reported as p < 0.05.   
 
 
 
 
 
 
 
Table 1 – Primer sequences used for real-time qPCR analysis 
Gene Protein 5’-Forward Primer-3’ 5'-Reverse Primer-3' 
Amplicon 
Size 
36-B4 
Acidic ribosomal 
phosphoprotein PO 
GCAGACAACGTGGGCTCCAAGCAGAT GGTCCTCCTTGGTGAACACGAAGCCC 190 
Adipoq Adiponectin CAACCAACAGAATCATTATG GGTAAGAGAAGTAGTAGAGT 77 
MCP-1 
Monocyte 
chemoattractant 
protein-1 
TTCCTCCACCACCATGCAG CCAGCCGGCAACTGTGA 64 
Pparg PPARγ CACAATGCCATCAGGTTTGG GCTGGTCGATATCACTGGAGATC 82 
Scarb1 SB-B1 CTCATCAAGCAGCAGGTGCTCA GAGGATTCGGGTGTCATGAA 710 
Results 
Epididymal Adipose SR-B1 mRNA increased in mice with high fat diet (HFD)-induced obesity 
A four-fold increase in SR-B1 expression was seen in the HFD mice, compared to the LFD control 
mice. The difference between the LFD and HFD SR-B1 expression was significant at a p value 
less than 0.05.  
 
SR-B1 expression in four fat depots in mice 
Mice were fed a high fat diet (HFD) for 10 weeks and the mRNA expression of SR-B1 in four 
different white adipose tissue depots showed no significant difference (Figure 4).  
Figure 3:  
Mice were fed a LFD or HFD for 16 weeks. 
Epididymal adipose tissue was analyzed for 
SR-B1 expression. Relative expression was 
standardized to the LFD control. Values are 
mean ± SEM. n = 4  
 
Figure 4: 
Adipose tissue from four different fat 
depots were analyzed for SR-B1 
expression. Values are standardized to 
the SR-B1 expression of the epidiymal 
tissue. Values are mean ± SEM.  
n =5, n=3 for retroperitoneal 
3T3-L1 Differentiation  
 
Cells were maintained in 10% calf-serum until 100% confluent (Figure 5a) before being treated 
with a differentiation cocktail comprised of isobutyl-methylxanthine, insulin and dexamethasone. 
There was lipid accumulation 12 days after differentiation (Figure 5b).  
 
SR-B1 mRNA is increased in mature adipocytes 
Cells at 70% confluence, 100% confluence, and Day 0 of differentiation were combined into “pre-
adipocytes” for mRNA analysis of SR-B1. Post-differentiation days 3 and 7 were combined into 
“mature adipocytes.” There is about a four-fold increase in SR-B1 expression between the pre-
adipocytes and mature adipocytes and the difference is significant at p <0.001 (Figure 6).  
Figure 6:  
The SR-B1 mRNA expression levels were 
measured pre-differentiation (pre-adipocytes) 
and post-differentiation (mature adipocytes). 
Values are mean ± SEM. n = 3 
Figure 5a-b:  
3T3-L1 pre-adipocytes at 
100% confluence (A), 
mature 3T3-L1 adipocytes 
12 days after differentiation 
(B) 
a b 
SR-B1 knockdown after siRNA transfection protocol 
An approximate 70% knockdown in SR-B1 was observed 
in the cells treated with SR-B1 siRNA (Figure 7). The 
change was significant at p <0.05. The scramble siRNA is 
a negative control sequence. Because the sequence does 
not complement any gene sequence, there should not be 
any change in gene expression. After the cells were 
transfected with the appropriate siRNA sequence, gene 
expression was analyzed using Rplp0 (36-B4) as a reference 
gene.   
 
Transfected 3T3-L1 cells treated with lipopolysaccharides (LPS)  
 
 
 
 
 
Figure 7: Mature 3T3-L1 adipocytes were 
treated with scramble siRNA or SR-B1 
siRNA to determine the efficiency of the 
transfection protocol. Relative expression of 
SR-B1 was standardized to the scramble 
siRNA. Values are mean ± SEM. n = 3  
Figure 8 (a-d): Mature 
3T3-L1 cells were 
transfected with scramble 
siRNA or SR-B1 siRNA 
for 48 hours and exposed 
to 10 g/mL LPS for 4 
hours. Gene expression 
was standardized to 
scramble siRNA+MCM. 
Values are mean ± SEM. 
n = 3   
*p <0.05 with t-test 
SR-B1 mRNA expression decreased significantly with SR-B1 siRNA in the presence of LPS 
(Figure 8a), demonstrating that SR-B1 was suppressed with the transfection in the stimulated 
condition. There is no significant change in PPARγ mRNA after SR-B1 suppression or in the 
presence of MCM (Figure 8b). When SR-B1 siRNA was added, AdipoQ mRNA expression 
tended to decrease in the presence of MCM, with a p-value of 0.0596 (Figure 8c). MCP-1 
expression increased with MCM; however, its expression in cells transfected with SR-B1 siRNA 
is was not different than the scramble siRNA (Figure 8d).  
 
Transfected cells treated with macrophage-conditioned media (MCM) 
 
 
Figure 9 (a-d): Mature 
3T3-L1 cells were 
transfected with 
scramble siRNA or SR-
B1 siRNA for 48 hours 
and exposed to 1 mL 
MCM for 4 hours. Gene 
expression was 
standardized to 
scramble siRNA+LPS. 
Values are mean ± 
SEM. n = 3   
*p <0.05 with t-test 
SR-B1 mRNA was decreased in the presence of MCM with SR-B1 siRNA (Figure 9a), but there 
were no significant changes in PPARγ. AdipoQ mRNA expression between siRNA conditions 
(Figure 9b-c). MCP-1 increased significantly in the presence of LPS in cells treated with either 
scramble siRNA or SR-B1 siRNA (Figure 9d). There was no significant difference in MCP-1 
expression between either siRNA conditions treated with LPS (Figure 9d).  
 
Discussion  
SR-B1 plays a role in cholesterol metabolism by binding HDL and facilitating the selective 
transportation of cholesteryl esters across the plasma membrane.9 Additionally, it is involved in 
facilitating the bidirectional flux of free cholesterol across the membrane.9 Its significance in the 
liver has been extensively studied; however, its role in adipocytes has yet to be determined. One 
study has shown that SR-B1 deficiency in mice leads to altered adiposity, leading to the hypothesis 
that SR-B1 plays a role in lipid metabolism in adipocytes.28 There is, however, research that 
suggests that SR-B1 suppression is protective in obesity by being more resistant to hepatic lipid 
deposition.29 Adipose tissue was obtained from mice fed either a low-fat diet (LFD) with 10% kcal 
as fat or a high-fat diet (HFD) with 60% kcal as fat for 10 weeks and SR-B1 mRNA expression in 
the epididymal adipose tissue was found to be much higher in the mice fed a HFD. The significant 
difference suggests that SR-B1 may play a crucial role in adipose tissue expansion and energy 
storage.  
 Mice have multiple white adipose tissue depots in their body, including 
epididymal/perigonadal, mesenteric, inguinal and retroperitoneal tissues. After SR-B1 expression 
was found to be higher in HFD mice, it was hypothesized that SR-B1 expression might vary 
between the different adipose depots. Adipose tissue samples from the four depots were analyzed 
for SR-B1 expression to determine if there was a specific depot that SR-B1 expression was 
greatest. Analyzing the depots from five mice did not show any significant differences between 
the four depots, suggesting that SR-B1 might have a similar function across all white adipose tissue 
in mice.  
3T3-L1 pre-adipocytes need to be differentiated to mature adipocytes through a process 
that lasts about 14 days. It was hypothesized that SR-B1 may play a role at separate intervals during 
the differentiation process. Cells were obtained in TRIzol reagent at different time points in the 
differentiation process, including before maturation (70% and 100% confluency, day of 
differentiation), and during maturation (3 days after differentiation, and 7 days after 
differentiation). SR-B1 mRNA expression was significantly higher in the mature adipocytes than 
the pre-adipocytes; furthering the hypothesis that SR-B1 plays a significant role in adipogenic 
conditions.  
 To determine the impact that SR-B1 has on the metabolism of adipocytes, knockdown 
experiments using siRNA were conducted to silence the SR-B1 gene. Through three trials of the 
transfection protocol, SR-B1 expression was reduced by ~70% in the SR-B1 transfected cells, 
demonstrating that the SR-B1 siRNA and the transfection protocol were valid for use in future 
experiments.   
LPS was used to initiate an inflammatory response in the mature 3T3-L1 adipocytes. SR-
B1 has been shown to bind and internalize LPS24 and be anti-inflammatory in macrophages,25 so 
it was hypothesized that SR-B1 would be a similar role in adipocytes in the presence of LPS. In 
the LPS experiments, SR-B1 mRNA expression was significantly decreased in cells transfected 
with SR-B1 siRNA in the presence of LPS. The expressions of PPAR, MCP-1 and AdipoQ were 
also analyzed. PPAR and AdipoQ did not change significantly with the transfection or LPS 
stimulation.  MCP-1, an inflammatory chemokine, was induced with LPS treatment of mature 
adipocytes. The significant increase in MCP-1 observed in the transfected cells in the presence of 
LPS shows it is an effective inflammatory stimulant in adipocytes. However, no differences in 
MCP-1 expression were observed between scramble siRNA and SR-B1 siRNA conditions.  
Macrophage-conditioned media (MCM) contains inflammatory cytokines released from 
macrophages, such as TNF, which can initiate an immune response in the presence of adipocytes. 
The SR-B1 mRNA was significantly reduced in cells treated with SR-B1 siRNA in the presence 
of MCM, demonstrating that the transfection was effective. MCP-1 expression was significantly 
increased in the cells treated with scramble siRNA in the presence of LPS; however, the SR-B1 
suppressed cells had a trending increase in MCP-1 expression with a p value of 0.1384. These data 
provides preliminary  evidence that MCM can be used initiate an inflammatory response in 
adipocytes. Consistent with this, AdipoQ mRNA expression tended to decrease when cells were 
treated with MCM. However, there were no significant changes in PPAR. In healthy adipocytes, 
PPAR has a positive association with adipocyte maturation; however, there was no difference 
between the conditions.  
SR-B1 plays a role in adipose tissue, as shown by its increased expression in mice fed a 
HFD as well as mature adipocytes. While its role has been determined in hepatocytes, this study 
demonstrated its role in lipid metabolism. Its function in inflammation is inconclusive from this 
study due to the complications involved in transfecting mature adipocytes. These experiments 
demonstrated that LPS and MCM are both effective inflammatory stimulants in mature adipocytes, 
which can be used in future experiments regarding the role of SR-B1 in inflammation.  
 
 
Limitations  
In vitro studies are limited by the fact that cells are in an isolated environment that does 
not provide a complete understanding of lipid metabolism in vivo. Because the differentiation of 
adipocytes requires a longer time than other cell types, it was time-consuming to culture them until 
they were fully mature cells ready to be used for experiments. In the fall of 2016, there was 
contamination in the shared cell culture incubator, so cells could not be grown during the time of 
de-contamination and cleaning. Another limitation for this study was the lack of protein expression 
data to confirm SR-B1 knockdown. Transfection to suppress protein may require a longer 
transfection than the 48 hours conducted. Lastly, there are variations in MCM media based on the 
length of time that the macrophages were exposed to their media. Although both siRNA conditions 
received the same batches of MCM, it would be more effective in future experiment to collect 
MCM frequently and pool together to reduce variation across experiments.  
 
Future Directions  
In order to increase statistical power, more trials should be done to reduce experimental 
variation and error. With only three trials in both the LPS and MCM experiments and large 
variation in gene expression, no definitive conclusions can be made from this data. Due to time 
constraints, more trials were not able to be done for the inflammation experiments. Furthermore, 
the dose- and time-dependent responses were not studied. A 4-hour incubation period might not 
have been enough time to observe an effect on mRNA for some genes. Future studies will use a 
longer incubation period.  
Additionally, the expression of more genes could be tested to determine the effects of SR-
B1 knockdown on inflammatory pathways. The TNF and IL-1beta primers were used; however, 
there was no PCR signal, indicating that these genes are expressed at very low levels, if at all, in 
the mature adipocytes. Currently, there are some trends that can be pursued further in the future, 
such as increased MCP-1 when SR-B1 is knocked down in the presence of MCM. Western blot 
analysis can also be used to determine protein expression after knockdown. 
Finally, the function of SR-B1 in lipid homeostasis can be studied using BLT compounds, 
a class of small molecule chemical inhibitors that block lipid transport through selective uptake 
and efflux pathways.30 The effects of BLT compounds are highly specific to the SR-B1 pathway 
and do not affect several clathrin-dependent and -independent endocytic pathways, the secretory 
pathway, or the actin or tubulin cytoskeletal networks.30 Although under the influence of these 
compounds SR-B1 had a higher binding affinity to HDL, they prevented SR-B1 from efficiently 
transferring lipid.30 Out of the different BLT compounds identified, BLT-1 was the most potent 
inhibitor and can be used to modify SR-B1 activity and HDL metabolism at low micromolar 
concentrations.30 Therefore, using BLT-1 can help better understand the effect SR-B1 has on lipid 
metabolism.  
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